Lisanti Capital Growth’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-305,095
| Closed | -$3.84M | – | 126 |
|
|
2022
Q3 | $3.84M | Buy |
+305,095
| New | +$3.84M | 0.51% | 80 |
|
|
2022
Q2 | – | Sell |
-662,644
| Closed | -$10.8M | – | 105 |
|
|
2022
Q1 | $10.8M | Buy |
+662,644
| New | +$10.8M | 1.21% | 24 |
|
|
2021
Q4 | – | Sell |
-219,450
| Closed | -$3.15M | – | 119 |
|
|
2021
Q3 | $3.15M | Sell |
219,450
-122,735
| -36% | -$1.76M | 0.46% | 84 |
|
|
2021
Q2 | $5.41M | Sell |
342,185
-130,335
| -28% | -$2.06M | 0.67% | 66 |
|
|
2021
Q1 | $4.81M | Buy |
+472,520
| New | +$4.81M | 0.62% | 71 |
|
|
2019
Q2 | – | Sell |
-221,565
| Closed | -$1.8M | – | 100 |
|
|
2019
Q1 | $1.8M | Buy |
+221,565
| New | +$1.8M | 0.64% | 70 |
|